Healthcare


 Halozyme Therapeutics (NASDAQ:HALO) Nasdaq Composite Biopharma Platform

Halozyme Therapeutics (NASDAQ:HALO) Nasdaq Composite Biopharma Platform

December 29, 2025 12:00 AM PST| By Anmol Khazanchi

Halozyme Therapeutics develops drug-delivery platforms enabling subcutaneous biologic therapies, maintaining visibility in biopharmaceutical discussions connected to the nasdaq composite and innovation-focused healthcare sectors.

 Incyte Corporation (NASDAQ:INCY) Nasdaq Index Fund Pathway Science

Incyte Corporation (NASDAQ:INCY) Nasdaq Index Fund Pathway Science

December 29, 2025 12:00 AM PST| By Anmol Khazanchi

Incyte Corporation (NASDAQ:INCY) develops and commercializes novel oncology and inflammation therapies, appearing in broader healthcare and biotechnology conversations that include the Nasdaq index fund.

 SOPHiA GENETICS (NASDAQ:SOPH) Within Nasdaq Futures Focus

SOPHiA GENETICS (NASDAQ:SOPH) Within Nasdaq Futures Focus

December 29, 2025 12:00 AM PST| By Anmol Khazanchi

SOPHiA GENETICS (NASDAQ:SOPH) advances cloud-native genomic analytics and AI-driven clinical workflows, appearing in broader healthcare technology discussions connected to movements in nasdaq futures.

 Monopar Therapeutics (NASDAQ:MNPR) Sharpens Focus on Molecular Targeting

Monopar Therapeutics (NASDAQ:MNPR) Sharpens Focus on Molecular Targeting

December 29, 2025 12:00 AM PST| By Anmol Khazanchi

Monopar Therapeutics (NASDAQ:MNPR) is a clinical-stage biotechnology company developing targeted radiotherapeutics and next-generation antibody-drug conjugates to enhance precision in cancer treatment.

 Precigen (NASDAQ:PGEN) Advances Genetic Medicine Platforms

Precigen (NASDAQ:PGEN) Advances Genetic Medicine Platforms

December 29, 2025 12:00 AM PST| By Anmol Khazanchi

Precigen (NASDAQ:PGEN) focuses on genetic medicines through proprietary gene and cell therapy platforms, supporting targeted treatments across oncology, infectious diseases, and rare medical conditions.

 CeriBell Corp (NASDAQ:CBLL) Develops Integrated Hearing Solutions

CeriBell Corp (NASDAQ:CBLL) Develops Integrated Hearing Solutions

December 29, 2025 12:00 AM PST| By Anmol Khazanchi

CeriBell Corp (NASDAQ:CBLL) delivers automated newborn hearing screening solutions using OAE and ABR technologies, supporting early detection of auditory impairments across hospitals and clinical settings.

 Glaukos Corp (NYSE:GKOS) Shares Rise After Quarterly Results

Glaukos Corp (NYSE:GKOS) Shares Rise After Quarterly Results

December 24, 2025 08:07 AM PST| By Anmol Khazanchi

Glaukos Corporation (NYSE:GKOS) provides MIGS devices and drug-delivery technologies, combining precision medical engineering with innovative solutions for chronic eye disease management.

 Pfizer Inc (NYSE:PFE) Advances Biopharmaceutical Operations Globally

Pfizer Inc (NYSE:PFE) Advances Biopharmaceutical Operations Globally

December 24, 2025 08:00 AM PST| By Anmol Khazanchi

Pfizer Inc (NYSE:PFE) demonstrates operational strength in medicines and vaccines, with consistent quarterly earnings, global manufacturing, and structured dividend distribution in the biopharmaceutical sector.

 Pfizer (NYSE:PFE) Shares Flat After Clinical Update Disclosure

Pfizer (NYSE:PFE) Shares Flat After Clinical Update Disclosure

December 24, 2025 04:45 AM PST| By Anmol Khazanchi

An overview of Pfizer Inc operations, research activity, manufacturing reach, and sector classification, highlighting its role within healthcare and references such as the S&P 500.

 National Research Corp (NASDAQ:NRC) Nasdaq 100 Index Health Metrics

National Research Corp (NASDAQ:NRC) Nasdaq 100 Index Health Metrics

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

VEON delivers mobile, broadband, and digital services across emerging markets through its operating subsidiaries, maintaining visibility in broader market discussions connected to the nasdaq 100 index.

 Arcellx Inc (NASDAQ:ACLX) Nasdaq Composite Platform-Driven Biotech

Arcellx Inc (NASDAQ:ACLX) Nasdaq Composite Platform-Driven Biotech

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Arcellx (NASDAQ:ACLX) develops modular cell therapy platforms focused on oncology and immune control, maintaining visibility in biotechnology conversations shaped by the nasdaq composite.

 United Therapeutics (NASDAQ:UTHR) Nasdaq Index Targeted Biotech

United Therapeutics (NASDAQ:UTHR) Nasdaq Index Targeted Biotech

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

United Therapeutics (NASDAQ:UTHR) strengthens specialized healthcare through targeted therapies for rare conditions, remaining prominent in biotechnology discussions shaped by activity across the nasdaq index.

 AtriCure Inc (NASDAQ:ATRC) Nasdaq Index Medical Device Depth

AtriCure Inc (NASDAQ:ATRC) Nasdaq Index Medical Device Depth

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

AtriCure (NASDAQ:ATRC) develops specialized medical devices for cardiac rhythm disorders, remaining visible in healthcare conversations shaped by activity connected to the nasdaq index.

 Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech

Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Masimo (NASDAQ:MASI) supports global healthcare through noninvasive monitoring technologies, appearing in broader market conversations shaped by developments within the nasdaq 100 composition.

 Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech

Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Masimo (NASDAQ:MASI) supports global healthcare through noninvasive monitoring technologies, appearing in broader market conversations shaped by developments within the nasdaq 100 composition.

 Innoviva Inc (NASDAQ:INVA) Nasdaq Composite ETF Therapy Royalties

Innoviva Inc (NASDAQ:INVA) Nasdaq Composite ETF Therapy Royalties

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Innoviva (NASDAQ:INVA) operates as a royalty-focused life sciences company tied to respiratory therapies, appearing in broader biotechnology conversations shaped by the nasdaq composite etf.

 Dynavax Technologies (NASDAQ:DVAX) Nasdaq 100 Index Healthcare Focus

Dynavax Technologies (NASDAQ:DVAX) Nasdaq 100 Index Healthcare Focus

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Dynavax Technologies (NASDAQ:DVAX) focuses on immune-based vaccine development through proprietary platforms, remaining visible in broader healthcare discussions associated with the nasdaq 100 index.

 Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint

Merck & Co., Inc (NYSE:MRK) S&P 500 Companies Biotech Footprint

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Merck & Co., Inc. operates as a global biopharmaceutical leader with strengths in oncology, vaccines, and animal health, maintaining visibility among major healthcare firms grouped within s&p 500 companies.

 Medtronic plc (NYSE:MDT) S&P 500 Today Global Healthcare Presence

Medtronic plc (NYSE:MDT) S&P 500 Today Global Healthcare Presence

December 24, 2025 12:00 AM PST| By Anmol Khazanchi

Medtronic plc (NYSE:MDT) operates as a global medical technology leader across devices and therapies, appearing in broader healthcare market discussions shaped by activity linked to s&p 500 today.

 Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth

Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth

December 23, 2025 12:00 AM PST| By Anmol Khazanchi

Soleno Therapeutics (NASDAQ:SLNO) focuses on precision medicine and rare disease research, maintaining visibility in broader healthcare discussions that appear alongside developments tracked in nasdaq today.

Recent Articles






Investing Tips

Previous Next